WSJ
27 Jul 2026, 05:29 UTC · 2h ago
Argenx to Buy Forte Biosciences for $2.2 Billion
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
WSJ
27 Jul 2026, 05:29 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
What the story claims
1 claim · each scored for market impact
Forte is being acquired at a 41% premium to its last closing price. — A high acquisition premium typically triggers an immediate price surge toward the offer price and signals strong valuation of the target's assets.
+0.80Which stocks this story touches
The company is being acquired at a significant 41% premium to its closing price.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Continue reading
6 related stories
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
3h ago
